View Financial HealthAlexium International Group 배당 및 자사주 매입배당 기준 점검 0/6Alexium International Group 배당금을 지급한 기록이 없습니다.핵심 정보n/a배당 수익률-9.6%자사주 매입 수익률총 주주 수익률-9.6%미래 배당 수익률n/a배당 성장률n/a다음 배당 지급일n/a배당락일n/a주당 배당금n/a배당 성향n/a최근 배당 및 자사주 매입 업데이트업데이트 없음모든 업데이트 보기Recent updatesBoard Change • May 21Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 5 non-independent directors. Independent Non-Executive Director Paul Stenson was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Dec 16Alexium International Group Limited (ASX:AJX) acquired Microtek Laboratories, Inc. from CAVU Group.Alexium International Group Limited (ASX:AJX) acquired Microtek Laboratories, Inc. from CAVU Group on December 15, 2025. The consideration consists of common equity of Alexium International Group Limited to be issued for common equity of Microtek Laboratories, Inc. Alexium International Group Limited (ASX:AJX) completed the acquisition of Microtek Laboratories, Inc. from CAVU Group on December 15, 2025.공시 • Dec 15Alexium International Group Limited has filed a Follow-on Equity Offering in the amount of AUD 6.765987 million.Alexium International Group Limited has filed a Follow-on Equity Offering in the amount of AUD 6.765987 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,127,664,547 Price\Range: AUD 0.006 Transaction Features: Rights Offering공시 • Oct 22Alexium International Group Limited, Annual General Meeting, Nov 21, 2025Alexium International Group Limited, Annual General Meeting, Nov 21, 2025. Location: at the offices of pwc, level 17, one international towers, barangaroo nsw 2000 Australia공시 • Aug 04Alexium International Group Limited Announces Resignation of Bob Brookins as Chief Technology Officer and Executive Director, Effective August 4, 2025Alexium International Group Limited announces that the Company's Chief Technology Officer and Executive Director, Dr Bob Brookins, has given notice of his intention to resign his roles after over 10 years of service. After completion of his three months notice period, Dr Brookins will become a consultant to the Company supporting Alexium's Technical Team which will now be led by Mr. Nick Leitner. Dr Brookins's resignation from Alexium's Board of Directors will be effective from August 4.공시 • Oct 18Alexium International Group Limited, Annual General Meeting, Nov 20, 2024Alexium International Group Limited, Annual General Meeting, Nov 20, 2024. Location: at the offices of pwc, level 17, one international towers, barangaroo nsw 2000. AustraliaReported Earnings • Aug 30Full year 2024 earnings releasedFull year 2024 results: Revenue: US$5.89m (down 18% from FY 2023). Net loss: US$2.76m (loss narrowed 6.4% from FY 2023).New Risk • Aug 19New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €7.58m (US$8.36m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (27% average weekly change). Negative equity (-US$3.1m). Shareholders have been substantially diluted in the past year (140% increase in shares outstanding). Market cap is less than US$10m (€7.58m market cap, or US$8.36m).Board Change • Jul 11Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Carl Dennis was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.New Risk • May 15New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 139% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (27% average weekly change). Negative equity (-US$3.1m). Shareholders have been substantially diluted in the past year (139% increase in shares outstanding). Minor Risk Market cap is less than US$100m (€11.5m market cap, or US$12.4m).New Risk • May 08New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 47% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (25% average weekly change). Negative equity (-US$3.1m). Market cap is less than US$10m (€6.44m market cap, or US$6.92m). Minor Risk Shareholders have been diluted in the past year (47% increase in shares outstanding).Reported Earnings • Feb 29First half 2024 earnings released: US$0.003 loss per share (vs US$0.004 loss in 1H 2023)First half 2024 results: US$0.003 loss per share (improved from US$0.004 loss in 1H 2023). Revenue: US$2.77m (down 20% from 1H 2023). Net loss: US$1.96m (loss narrowed 17% from 1H 2023). Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has fallen by 52% per year, which means it is performing significantly worse than earnings.공시 • Dec 27+ 1 more updateAlexium International Group Limited has filed a Follow-on Equity Offering in the amount of AUD 0.5 million.Alexium International Group Limited has filed a Follow-on Equity Offering in the amount of AUD 0.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 38,461,538 Price\Range: AUD 0.013 Transaction Features: Subsequent Direct ListingNew Risk • Dec 20New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.5m free cash flow). Share price has been highly volatile over the past 3 months (20% average weekly change). Negative equity (-US$983k). Market cap is less than US$10m (€6.11m market cap, or US$6.71m). Minor Risk Shareholders have been diluted in the past year (2.4% increase in shares outstanding).공시 • Oct 26Alexium International Group Limited Announces Resignation of Stephen Cheney as Non-Executive Director, Effective 1 November 2023Alexium International Group Limited announced that Brigadier General Stephen Cheney, USMC (Ret) has advised the Company of his intention to resign as Non-Executive Director of Alexium, effective 1 November 2023. Mr. Cheney has been a Non-Executive Director of Alexium since April 2015 and has served on the Company's Audit, Nomination & Remuneration, and Risk Committees.New Risk • Oct 06New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.5m free cash flow). Share price has been highly volatile over the past 3 months (28% average weekly change). Negative equity (-US$983k). Market cap is less than US$10m (€7.94m market cap, or US$8.42m). Minor Risk Shareholders have been diluted in the past year (2.0% increase in shares outstanding).공시 • Sep 27Alexium International Group Limited, Annual General Meeting, Nov 15, 2023Alexium International Group Limited, Annual General Meeting, Nov 15, 2023, at 10:30 AUS Eastern Standard Time. Location: offices of Grant Thornton, Level 17, 383 Kent Street, 2000 Sydney New South Wales Australia Agenda: To consider the election of director.Reported Earnings • Aug 25Full year 2023 earnings released: US$0.005 loss per share (vs US$0.005 loss in FY 2022)Full year 2023 results: US$0.005 loss per share (in line with FY 2022). Revenue: US$7.21m (down 12% from FY 2022). Net loss: US$2.95m (loss narrowed 12% from FY 2022). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 46% per year, which means it is significantly lagging earnings.Reported Earnings • Feb 26First half 2023 earnings releasedFirst half 2023 results: Revenue: US$3.44m (down 35% from 1H 2022). Net loss: US$2.37m (loss widened 22% from 1H 2022).Board Change • Nov 01High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. CEO & Managing Director Billy Blackburn was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Board Change • Oct 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. CEO & Managing Director Billy Blackburn was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • Aug 26Full year 2022 earnings released: US$0.005 loss per share (vs US$0.002 loss in FY 2021)Full year 2022 results: US$0.005 loss per share (down from US$0.002 loss in FY 2021). Revenue: US$8.17m (up 12% from FY 2021). Net loss: US$3.36m (loss widened 133% from FY 2021). Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.Reported Earnings • Mar 01First half 2022 earnings: EPS in line with analyst expectations despite revenue beatFirst half 2022 results: US$0.003 loss per share (vs US$0.003 loss in 1H 2021). Revenue: US$5.28m (up 46% from 1H 2021). Net loss: US$1.95m (loss widened 8.9% from 1H 2021). Revenue exceeded analyst estimates by 176%. Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 28Full year 2021 earnings released: US$0.002 loss per share (vs US$0.013 loss in FY 2020)The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2021 results: Revenue: US$7.28m (up 20% from FY 2020). Net loss: US$1.45m (loss narrowed 76% from FY 2020). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings.Reported Earnings • Feb 26First half 2021 earnings released: US$0.003 loss per share (vs US$0.012 loss in 1H 2020)The company reported a solid first half result with reduced losses, improved revenues and improved control over expenses. First half 2021 results: Revenue: US$3.61m (up 14% from 1H 2020). Net loss: US$1.79m (loss narrowed 59% from 1H 2020). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 43% per year, which means it is significantly lagging earnings.지급의 안정성과 성장배당 데이터 가져오는 중안정적인 배당: 과거에 E7T 의 주당 배당금이 안정적이었는지 판단하기에는 데이터가 부족합니다.배당금 증가: E7T 의 배당금 지급이 증가했는지 판단하기에는 데이터가 부족합니다.배당 수익률 vs 시장Alexium International Group 배당 수익률 vs 시장E7T의 배당 수익률은 시장과 어떻게 비교되나요?구분배당 수익률회사 (E7T)n/a시장 하위 25% (DE)1.5%시장 상위 25% (DE)4.5%업계 평균 (Chemicals)3.7%분석가 예측 (E7T) (최대 3년)n/a주목할만한 배당금: 회사가 최근 지급을 보고하지 않았기 때문에 하위 25%의 배당금 지급자에 대해 E7T 의 배당 수익률을 평가할 수 없습니다.고배당: 회사가 최근 지급을 보고하지 않았기 때문에 배당금 지급자의 상위 25%에 대해 E7T 의 배당 수익률을 평가할 수 없습니다.주주 대상 이익 배당수익 보장: 배당금 지급이 수익으로 충당되는지 확인하기 위해 E7T 의 지급 비율을 계산하기에는 데이터가 부족합니다.주주 현금 배당현금 흐름 범위: E7T 에서 지급을 보고하지 않았기 때문에 배당 지속 가능성을 계산할 수 없습니다.높은 배당을 제공하는 우량 기업 찾기7D1Y7D1Y7D1YDE 시장에서 배당이 강한 기업.View Management기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 17:59종가2026/05/22 00:00수익2025/12/31연간 수익2025/06/30데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Alexium International Group Limited는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Board Change • May 21Less than half of directors are independentFollowing the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 5 non-independent directors. Independent Non-Executive Director Paul Stenson was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Dec 16Alexium International Group Limited (ASX:AJX) acquired Microtek Laboratories, Inc. from CAVU Group.Alexium International Group Limited (ASX:AJX) acquired Microtek Laboratories, Inc. from CAVU Group on December 15, 2025. The consideration consists of common equity of Alexium International Group Limited to be issued for common equity of Microtek Laboratories, Inc. Alexium International Group Limited (ASX:AJX) completed the acquisition of Microtek Laboratories, Inc. from CAVU Group on December 15, 2025.
공시 • Dec 15Alexium International Group Limited has filed a Follow-on Equity Offering in the amount of AUD 6.765987 million.Alexium International Group Limited has filed a Follow-on Equity Offering in the amount of AUD 6.765987 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 1,127,664,547 Price\Range: AUD 0.006 Transaction Features: Rights Offering
공시 • Oct 22Alexium International Group Limited, Annual General Meeting, Nov 21, 2025Alexium International Group Limited, Annual General Meeting, Nov 21, 2025. Location: at the offices of pwc, level 17, one international towers, barangaroo nsw 2000 Australia
공시 • Aug 04Alexium International Group Limited Announces Resignation of Bob Brookins as Chief Technology Officer and Executive Director, Effective August 4, 2025Alexium International Group Limited announces that the Company's Chief Technology Officer and Executive Director, Dr Bob Brookins, has given notice of his intention to resign his roles after over 10 years of service. After completion of his three months notice period, Dr Brookins will become a consultant to the Company supporting Alexium's Technical Team which will now be led by Mr. Nick Leitner. Dr Brookins's resignation from Alexium's Board of Directors will be effective from August 4.
공시 • Oct 18Alexium International Group Limited, Annual General Meeting, Nov 20, 2024Alexium International Group Limited, Annual General Meeting, Nov 20, 2024. Location: at the offices of pwc, level 17, one international towers, barangaroo nsw 2000. Australia
Reported Earnings • Aug 30Full year 2024 earnings releasedFull year 2024 results: Revenue: US$5.89m (down 18% from FY 2023). Net loss: US$2.76m (loss narrowed 6.4% from FY 2023).
New Risk • Aug 19New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €7.58m (US$8.36m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (27% average weekly change). Negative equity (-US$3.1m). Shareholders have been substantially diluted in the past year (140% increase in shares outstanding). Market cap is less than US$10m (€7.58m market cap, or US$8.36m).
Board Change • Jul 11Less than half of directors are independentFollowing the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Non-Executive Director Carl Dennis was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
New Risk • May 15New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 139% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (27% average weekly change). Negative equity (-US$3.1m). Shareholders have been substantially diluted in the past year (139% increase in shares outstanding). Minor Risk Market cap is less than US$100m (€11.5m market cap, or US$12.4m).
New Risk • May 08New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 47% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (25% average weekly change). Negative equity (-US$3.1m). Market cap is less than US$10m (€6.44m market cap, or US$6.92m). Minor Risk Shareholders have been diluted in the past year (47% increase in shares outstanding).
Reported Earnings • Feb 29First half 2024 earnings released: US$0.003 loss per share (vs US$0.004 loss in 1H 2023)First half 2024 results: US$0.003 loss per share (improved from US$0.004 loss in 1H 2023). Revenue: US$2.77m (down 20% from 1H 2023). Net loss: US$1.96m (loss narrowed 17% from 1H 2023). Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has fallen by 52% per year, which means it is performing significantly worse than earnings.
공시 • Dec 27+ 1 more updateAlexium International Group Limited has filed a Follow-on Equity Offering in the amount of AUD 0.5 million.Alexium International Group Limited has filed a Follow-on Equity Offering in the amount of AUD 0.5 million. Security Name: Ordinary Shares Security Type: Common Stock Securities Offered: 38,461,538 Price\Range: AUD 0.013 Transaction Features: Subsequent Direct Listing
New Risk • Dec 20New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.5m free cash flow). Share price has been highly volatile over the past 3 months (20% average weekly change). Negative equity (-US$983k). Market cap is less than US$10m (€6.11m market cap, or US$6.71m). Minor Risk Shareholders have been diluted in the past year (2.4% increase in shares outstanding).
공시 • Oct 26Alexium International Group Limited Announces Resignation of Stephen Cheney as Non-Executive Director, Effective 1 November 2023Alexium International Group Limited announced that Brigadier General Stephen Cheney, USMC (Ret) has advised the Company of his intention to resign as Non-Executive Director of Alexium, effective 1 November 2023. Mr. Cheney has been a Non-Executive Director of Alexium since April 2015 and has served on the Company's Audit, Nomination & Remuneration, and Risk Committees.
New Risk • Oct 06New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 2.0% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$1.5m free cash flow). Share price has been highly volatile over the past 3 months (28% average weekly change). Negative equity (-US$983k). Market cap is less than US$10m (€7.94m market cap, or US$8.42m). Minor Risk Shareholders have been diluted in the past year (2.0% increase in shares outstanding).
공시 • Sep 27Alexium International Group Limited, Annual General Meeting, Nov 15, 2023Alexium International Group Limited, Annual General Meeting, Nov 15, 2023, at 10:30 AUS Eastern Standard Time. Location: offices of Grant Thornton, Level 17, 383 Kent Street, 2000 Sydney New South Wales Australia Agenda: To consider the election of director.
Reported Earnings • Aug 25Full year 2023 earnings released: US$0.005 loss per share (vs US$0.005 loss in FY 2022)Full year 2023 results: US$0.005 loss per share (in line with FY 2022). Revenue: US$7.21m (down 12% from FY 2022). Net loss: US$2.95m (loss narrowed 12% from FY 2022). Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has fallen by 46% per year, which means it is significantly lagging earnings.
Reported Earnings • Feb 26First half 2023 earnings releasedFirst half 2023 results: Revenue: US$3.44m (down 35% from 1H 2022). Net loss: US$2.37m (loss widened 22% from 1H 2022).
Board Change • Nov 01High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. CEO & Managing Director Billy Blackburn was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Board Change • Oct 02High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. CEO & Managing Director Billy Blackburn was the last director to join the board, commencing their role in 2022. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • Aug 26Full year 2022 earnings released: US$0.005 loss per share (vs US$0.002 loss in FY 2021)Full year 2022 results: US$0.005 loss per share (down from US$0.002 loss in FY 2021). Revenue: US$8.17m (up 12% from FY 2021). Net loss: US$3.36m (loss widened 133% from FY 2021). Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings.
Reported Earnings • Mar 01First half 2022 earnings: EPS in line with analyst expectations despite revenue beatFirst half 2022 results: US$0.003 loss per share (vs US$0.003 loss in 1H 2021). Revenue: US$5.28m (up 46% from 1H 2021). Net loss: US$1.95m (loss widened 8.9% from 1H 2021). Revenue exceeded analyst estimates by 176%. Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 28Full year 2021 earnings released: US$0.002 loss per share (vs US$0.013 loss in FY 2020)The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2021 results: Revenue: US$7.28m (up 20% from FY 2020). Net loss: US$1.45m (loss narrowed 76% from FY 2020). Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 19% per year, which means it is significantly lagging earnings.
Reported Earnings • Feb 26First half 2021 earnings released: US$0.003 loss per share (vs US$0.012 loss in 1H 2020)The company reported a solid first half result with reduced losses, improved revenues and improved control over expenses. First half 2021 results: Revenue: US$3.61m (up 14% from 1H 2020). Net loss: US$1.79m (loss narrowed 59% from 1H 2020). Over the last 3 years on average, earnings per share has increased by 11% per year but the company’s share price has fallen by 43% per year, which means it is significantly lagging earnings.